rome and Mumps

To evaluate the effectiveness of the measles-mumps-rubella (MMR) vaccine in reducing hospitalizations for infectious disease, targeted and not targeted, as well as from respiratory diseases in children in Rome.. The cohort was recomposed through record linkage of 2 archives (vaccination register and hospital discharge records.. The analysis included 11,004 children. 20.9% did not receive the MMR vaccination, 49% and 30.1% received one and 2 doses. There were no hospitalizations for rubella, 2 for mumps, and 12 for measles. The vaccine was highly protective against measles and mumps hospitalizations (HR = 0.10; 95% CI: 0.03.0.34). Regarding all infectious diseases there were 414 hospitalizations, and the vaccine was protective (HR = 0.29; 95% CI: 0.25 to 0.34). Concerning respiratory diseases, there were 809 admissions (7.4%), and the vaccine was highly protective (HR: 0.18; 95% CI: 0.07 to 0.48).. MMR vaccination is effective for the primary prevention of target and not targeted infectious diseases and may also limit hospitalizations for respiratory diseases.

Topics: Child; Child, Preschool; Cohort Studies; Female; Hospitalization; Humans; Infant; Male; Measles; Measles-Mumps-Rubella Vaccine; Mumps; Respiratory Tract Infections; Retrospective Studies; Rome; Rubella; Vaccination; Vaccines, Attenuated

Topics: Adolescent; Allergy and Immunology; Antibodies; Child; Coxsackievirus Infections; Enterovirus B, Human; Enterovirus Infections; Epidemiology; Geriatrics; Herpesviridae Infections; Humans; Incidence; Infant; Influenza, Human; Italy; Mumps; Orthomyxoviridae; Orthomyxoviridae Infections; Poliomyelitis; Psittacosis; Respiratory Tract Infections; Rome; Virus Diseases